Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Alvelestat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mereo BioPharma Receives FDA Fast Track Designation for Alvelestat
    Mereo BioPharma Receives FDA Fast Track Designation for Alvelestat

    17 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/17/2535304/0/en/Mereo-BioPharma-Receives-FDA-Fast-Track-Designation-for-Alvelestat-for-Treatment-of-Alpha-1-Antitrypsin-Deficiency-AATD-associated-Lung-Disease.html

    GLOBENEWSWIRE
    17 Oct 2022
    Share Share
    Mereo BioPharma’s Alvelestat Meets Endpoints in ASTRAEUS Trial in AATD
    Mereo BioPharma’s Alvelestat Meets Endpoints in ASTRAEUS Trial in AATD

    10 May 2022

    // TRIALSITENEWS

    https://www.trialsitenews.com/p/trialsitenews/mereo-biopharmas-alvelestat-meets-endpoints-in-astraeus-trial-in-patients-with-alpha-1-antitrypsin-deficiency-associated-emphysema-a1c221e1

    TRIALSITENEWS
    10 May 2022
    Share Share
    Mereo Announces Initiation of Placebo-Controlled Ph 1b/2 Trial with Alvelestat
    Mereo Announces Initiation of Placebo-Controlled Ph 1b/2 Trial with Alvelestat

    25 Aug 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/08/25/2083126/0/en/Mereo-BioPharma-Announces-Initiation-of-Placebo-Controlled-Phase-1b-2-Clinical-Trial-with-Alvelestat-in-COVID-19-Respiratory-Disease.html

    GLOBENEWSWIRE
    25 Aug 2020
    Share Share
    Celgene says no to Mereo’s cancer drug etigilimab
    Celgene says no to Mereo’s cancer drug etigilimab

    22 Jun 2019

    // Phil Taylor PM LIVE

    http://www.pmlive.com/pharma_news/celgene_says_no_to_mereos_cancer_drug_etigilimab_1291381

    Phil Taylor PM LIVE
    22 Jun 2019
    Share Share